Medical Research News and Research

RSS

Findings may help develop new antiviral drugs for influenza

Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.

22 Dec 2009

United States Congress approves additional $15 million in research funding for lung cancer

Today, the United States Congress approved an additional $15 million in research funding for lung cancer as part of the fiscal year 2010 Department of Defense (DOD) Appropriations package.

20 Dec 2009

Distinguished Young Scholars Program completed by W. M. Keck Foundation

The W. M. Keck Foundation, a leading supporter of pioneering medical research, science and engineering, today announced the successful completion of its Distinguished Young Scholars Program, a groundbreaking initiative created to give the nation's most promising young scientists the resources they need to pursue potentially breakthrough research projects in biomedical research.

19 Dec 2009

SAIC receives multiple-award contract to support BUMED throughout the U.S.

Science Applications International Corporation (SAIC) today announced it has been awarded a prime contract by the U.S. Army Research, Development and Engineering Command Acquisition Center - Natick Contracting Division to support the U.S. Navy's Chief Bureau of Medicine and Surgery (BUMED) for Medical Research and Development, and their subordinate research and development commands.

18 Dec 2009

JDRF to work with Johnson & Johnson to develop drug targets and pathways for treating diabetes

The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes.

18 Dec 2009

Statistics show China may surpass U.S. in academic output by next decade

Data from a recent Thomson Reuters study show that Chinese research output has increased from just over 20,000 papers in 1998 to nearly 112,000 in 2008.

18 Dec 2009

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

The Hebrew University of Jerusalem Kuvin Center for the Study of Infectious and Tropical Diseases has received a $5 million grant from the Bill & Melinda Gates Foundation for research into visceral leishmaniasis in Ethiopia.

17 Dec 2009

Switching between A-rated anti-epileptic drug formulations does not increase seizure risk

Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, announced today results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations. The study found no evidence that switching between A-rated anti-epileptic drugs, including brand to generic substitution, was associated with increased emergency room visits or hospitalizations for epilepsy.

17 Dec 2009

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus -- in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.

17 Dec 2009

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

17 Dec 2009

Arrayit Diagnostics to begin marketing its OvaDx Pre-Symptomatic Ovarian Cancer Blood Test in 2010

John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development - the rights to which have been assigned exclusively to the Company by Arrayit Corporation.

17 Dec 2009

Human embryonic stem cell lines lack genetic diversity, says study

The most widely used human embryonic stem cell lines lack genetic diversity, a finding that raises social justice questions that must be addressed to ensure that all sectors of society benefit from stem cell advances, according to a University of Michigan research team.

17 Dec 2009

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

17 Dec 2009

$15 million federal funds for new cancer research program

As a result of C3: Colorectal Cancer Coalition's advocacy efforts, $15 million for a new peer reviewed cancer research program is included in the final Fiscal Year 2010 Defense Appropriations Bill.

17 Dec 2009

Nitric oxide opens up new treatment option for septic shock

Scientists at VIB and Ghent University in Flanders, Belgium have found an unexpected ally for the treatment of septic shock, the major cause of death in intensive care units.

16 Dec 2009

Celgene announces positive data from its apremilast Phase IIb study for plaque-type psoriasis

Celgene Corporation announced clinical data from an investigational Phase IIb, double-blind, placebo-controlled study of apremilast (CC-10004) in patients with moderate-to-severe plaque-type psoriasis (PSOR-005). This was a 352-patient, multi-center study in which patients received either 10mg, 20mg or 30mg of apremilast twice per day (BID), or placebo.

15 Dec 2009

IDBS included in recent research report from Gartner

IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced that it has been included in a recent research report from Gartner, "Who's Who in Interactive Visualization for BI," by James Richardson, published November 13, 2009.

15 Dec 2009

Microbicide does not reduce women's risk of HIV infection, study shows

Pro 2000, a vaginal microbicide gel designed to reduce women's risk of HIV infection, showed "no evidence that it reduces the risk of HIV infection," according to the results of a series of clinical trials in Africa, Britain's Medical Research Council (MRC) said on Monday, Reuters reports.

15 Dec 2009

NBC News examines 'fastest growing' vector-borne disease: Dengue

Dengue is the "fastest growing" vector-borne disease worldwide, NBC News' "World Blog" writes in a story examining the disease. "It used to be contained largely to south-east Asia, but has been spreading, and is now found in South America, Africa, south Asia and parts of Australia.

15 Dec 2009

Ted and Jane Von Voigtlander Foundation gifts $15 million to University of Michigan Health System

The University of Michigan Health System has received a $15 million gift from the Ted and Jane Von Voigtlander Foundation, the largest gift ever made to the Health System for women's health. It will support the construction of a new women's hospital.

15 Dec 2009

Medical Research News and Research

Findings may help develop new antiviral drugs for influenza

United States Congress approves additional $15 million in research funding for lung cancer

Distinguished Young Scholars Program completed by W. M. Keck Foundation

SAIC receives multiple-award contract to support BUMED throughout the U.S.

JDRF to work with Johnson & Johnson to develop drug targets and pathways for treating diabetes

Statistics show China may surpass U.S. in academic output by next decade

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

Switching between A-rated anti-epileptic drug formulations does not increase seizure risk

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

Arrayit Diagnostics to begin marketing its OvaDx Pre-Symptomatic Ovarian Cancer Blood Test in 2010

Human embryonic stem cell lines lack genetic diversity, says study

JCTM established to advance new research toward clinical applications

$15 million federal funds for new cancer research program

Nitric oxide opens up new treatment option for septic shock

Celgene announces positive data from its apremilast Phase IIb study for plaque-type psoriasis

IDBS included in recent research report from Gartner

Microbicide does not reduce women's risk of HIV infection, study shows

NBC News examines 'fastest growing' vector-borne disease: Dengue

Ted and Jane Von Voigtlander Foundation gifts $15 million to University of Michigan Health System

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News